Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caner Saygin

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Journal of Ovarian Research|April 23, 2021
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumorsKatie K Crean-Tate, Chad Braley, Goutam Dey, et al.
Blood Cancer Journal|January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Human Pathology|April 22, 2022
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomasFaiza Siddiqui, Vanessa Perez Silos, Kennosuke Karube, et al.
Leukemia & Lymphoma|July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete responseCaner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
Molecular Cancer Therapeutics|March 4, 2026
Targeting menin in T-lineage acute lymphoblastic leukemiaKathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold, et al.
JCI Insight|June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemiaEileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Blood Advances|August 24, 2022
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignanciesCaner Saygin, Gregory Roloff, Christopher N Hahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Journal of Ovarian Research|April 23, 2021
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumorsKatie K Crean-Tate, Chad Braley, Goutam Dey, et al.
Blood Cancer Journal|January 12, 2018
Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1Caner Saygin, Cassandra Hirsch, Bartlomiej Przychodzen, et al.
Human Pathology|April 22, 2022
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomasFaiza Siddiqui, Vanessa Perez Silos, Kennosuke Karube, et al.
Leukemia & Lymphoma|July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete responseCaner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.
Ejhaem|June 16, 2025
Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax TherapyRafael Madero-Marroquin, Joseph Cannova, Emily Dworkin, et al.
Molecular Cancer Therapeutics|March 4, 2026
Targeting menin in T-lineage acute lymphoblastic leukemiaKathryn Shimamoto, Diren Arda Karaoglu, Olivia Arnold, et al.
JCI Insight|June 20, 2020
LC-FACSeq is a method for detecting rare clones in leukemiaEileen Y Hu, James S Blachly, Caner Saygin, et al.
Blood Advances|December 1, 2023
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adultsHannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, et al.
Blood Advances|August 24, 2022
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignanciesCaner Saygin, Gregory Roloff, Christopher N Hahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Genomic Subtype Influences BH3 Mimetic Drug Sensitivity and Synergy with Cytotoxic Chemotherapeutics in T-cell Acute Lymphoblastic LeukemiaSatoshi Yoshimura, Yizhen Li, Shutaro Inoue, et al.
Pageof 7